In ILDE, patients experiencing ILD had generally good outcomes, and many could resume the cancer treatments. Implementing best practices to prompt diagnosis and management of ILD is critical to treat a potentially severe adverse effect of new drugs, while not affecting patients' outcomes. Research efforts to identify risk factors is warranted, to implement risk-based monitoring schedules and develop ad hoc strategies to improve the cure rates of ILD.
Keyphrases
- interstitial lung disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- clinical trial
- chronic kidney disease
- systemic sclerosis
- risk factors
- peritoneal dialysis
- healthcare
- primary care
- prognostic factors
- rheumatoid arthritis
- emergency department
- adipose tissue
- quality improvement
- patient reported outcomes
- skeletal muscle
- young adults
- early onset
- idiopathic pulmonary fibrosis
- open label
- insulin resistance
- weight loss
- papillary thyroid